- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
NHI-2 is an inihbitor of Lactate dehydrogenase-A (LDH-A, LDHA), a key enzyme necessary to sustain glycolysis, the major pathway used by many cancer cells for cell growth and proliferation (the Warburg effect). NHI-2 has anti-glycolytic activity against a variety of cancer cells. NHI-2 inhibited cell growth of pancreatic cancer LPC006 and PANC-1 cells and enhanced the antiproliferative effects of Gemcitabine and caused apoptosis in colon cancer HCT116 cells.
NHI-2 is an inihbitor of Lactate dehydrogenase-A (LDH-A, LDHA).
NHI-2 possesses highr cell permeability.
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | ON(C(C(OC)=O)=C1)C2=C1C(C(F)(F)F)=CC(C3=CC=CC=C3)=C2 |
| InChI | 1S/C17H12F3NO3/c1-24-16(22)15-9-12-13(17(18,19)20)7-11(8-14(12)21(15)23)10-5-3-2-4-6-10/h2-9,23H,1H3 |
| InChI key | YPPFWRWCZNXINO-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 2528.88
-
¥ 2622.09
-
¥ 1451.54
-
¥ 4039.86
-
¥ 8293.41
-
询价
-
询价
-
询价
-
询价
-
¥ 1724.25
-
询价
-
询价
-
¥ 6330.00
-
¥ 2666.57
-
¥ 4011.97
-
¥ 1586.69
-
¥ 5804.96
-
¥ 145427.01
-
¥ 14985.93
微信小程序
7X24小时在线咨询